Coca-Cola Europacific Partners

Public consensus   -   Last updated 10/07/26

Contributors

  • 17 H1 FY26 based on
  • 17 FY26 based on
  • 17 Q2 FY26 based on
  • 17 FY27 based on
  • 16 FY28 based on
Reporting currency: EUR
Reporting unit: Millions
H1 FY26
CONSENSUS
10/07/26
FY26
CONSENSUS
10/07/26
Q2 FY26
CONSENSUS
10/07/26
FY27
CONSENSUS
10/07/26
FY28
CONSENSUS
10/07/26
Comparable (€m)
Revenue: Europe
7,877
15,872
4,328
16,374
16,870
Operating profit: Europe
1,123
2,290
n/a
2,430
2,567
Revenue: APS
2,826
5,628
1,374
5,926
6,261
Operating profit: APS
346
706
n/a
771
845
Revenue: Total CCEP
10,705
21,497
5,704
22,300
23,131
Gross profit: TOTAL CCEP
3,762
7,660
1,873
7,960
8,294
Operating profit: TOTAL CCEP
1,468
2,997
3,354
3,201
3,412
Net finance costs: TOTAL CCEP
129
261
76
269
281
Taxes: TOTAL CCEP
346
707
240
756
808
Profit after taxes: TOTAL CCEP
990
2,017
682
2,153
2,296
Non-controlling interests: TOTAL CCEP
26
43
16
48
51
Diluted EPS (€): TOTAL CCEP
2.15
4.45
1.47
4.87
5.32
Growth Rates: Europe
Volume growth (%) – NOT adjusted for consumption days
4.2
1.0
0.9
0.7
0.9
Comparable FX-Neutral revenue per unit case growth (%)
1.7
2.0
2.2
2.5
2.2
Comparable FX-Neutral revenue growth (%)
6.0
3.1
2.9
3.2
3.1
Comparable total revenue growth (%)
5.5
3.0
2.6
3.2
3.1
Growth Rates: APS
Volume growth (%) – NOT adjusted for consumption days
5.7
2.6
2.4
2.9
3.2
Comparable FX-Neutral revenue per unit case growth (%)
(0.4)
0.9
(0.7)
2.4
2.3
Comparable FX-Neutral revenue growth (%)
5.2
3.5
1.8
5.3
5.4
Comparable total revenue growth (%)
0.8
2.3
0.5
5.0
5.2
Growth Rates: TOTAL CCEP
Volume growth (%) – NOT adjusted for consumption days
4.7
1.6
1.4
1.5
1.7
Comparable FX-Neutral revenue per unit case growth (%)
0.9
1.6
1.2
2.2
2.0
Comparable FX-Neutral revenue growth (%)
5.7
3.2
2.6
3.7
3.7
Comparable total revenue growth (%)
4.2
2.9
2.1
3.7
3.8
Comparable FX-Neutral cost of sales per unit case growth (%)
1.2
1.6
n/a
2.1
1.6
Comparable FX-Neutral operating profit growth (%)
6.9
7.1
n/a
6.7
6.7
Comparable operating profit growth (%)
5.7
6.7
n/a
6.8
6.6
Comparable FX-neutral diluted EPS growth (%)
7.6
8.6
n/a
9.3
9.2
Select metrics: TOTAL CCEP
Gross profit margin (%)
35.1
35.6
33.5
35.7
35.9
Operating profit margin (%)
13.7
13.9
17.9
14.4
14.8
Tax rate (%)
26.0
25.9
26.0
25.9
25.9
Other Items: TOTAL CCEP
Dividend per share (€)
0.83
2.21
0.82
2.40
2.62
Depreciation & amortisation (€m)
475
945
246
973
1,003
Capital expenditure (€m)
489
1,047
280
1,064
1,094
Free cashflow (€m)
560
1,782
415
2,006
2,103
Net debt/(cash) (€m)
9,987
9,928
9,856
9,859
9,838
Dividend payment (€m)
370
977
n/a
1,041
1,108

Disclaimer

Coca-Cola Europacific Partners plc (the “Company”) is not authorised or regulated by the UK Financial Conduct Authority and may not provide investment advice. The consensus data should not be construed as an invitation, inducement or recommendation to buy or sell securities of the Company or to engage in any other form of investment activity. In addition, the consensus data is not intended to constitute a financial promotion within the meaning of section 21 of the Financial Services and Markets Act 2000.

The consensus data are based on submissions from registered investment analysts as to the Company’s expected future performance. It is therefore speculative and forward-looking and subject to a number of uncertainties that may impact the Company’s actual performance. Vuma Financial Ltd. collects and analyses the submissions which form the basis of the consensus data and any Company information provided is publicly disclosed and available on the Company’s website, from Euronext.com, londonstockexchange.com and/or filed with the US Securities and Exchange Commission . The figures presented represent the arithmetic average of the submissions that have been provided, with each submission being given equal weight. Moreover, the data has not been adjusted to exclude any submission. It is assumed that the submissions reflect the analysts’ genuine opinions, forecasts, estimates, projections and predictions and that the analysts will, if relevant, identify and disclose all conflicts of interest that are known or reasonably expected to be known to relate to them. No analyst has been paid a fee, commission or received a non-monetary benefit from the Company or any person connected to the Company for their submission.